Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT2 Inhibitors

NCT07421518 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.

NCT NCT07421518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07421518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT2 Inhibitors
Lead sponsor
AdventHealth Translational Research Institute
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
April 30, 2030
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes, type 2 diabetes